Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022
PaperCitations, authors & open-access status
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 185 citations, 2022 year and diamond oa status.
185
Citations
2022
Year
diamond
OA Status